Pharmaceuticals & Biotechnology

GlaxoSmithKline Pharmaceuticals Limited

ISIN: INE159A01016 · Data as of May 2026
Share: WhatsApp ✕ X
Search another stock:
Active Funds Holding
110
vs Last Month
+7 funds
Total Value
₹1,700.79 Cr
Avg Weight
0.59%
New Entries
7
Exits
9
ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.
Mid Cap Rank #206
₹23.73 K Cr
Avg Mkt Cap · Jul-Dec 2022 (3yr ago)
₹46.78 K Cr
Avg Mkt Cap · Jul-Dec 2025 (latest)
+97.2%
3yr change
SEBI · AMFI Market Cap List
📋 What Changed This Month GlaxoSmithKline Pharmaceuticals Limited is currently held by 110 active mutual funds with total exposure of ₹1,700.79 Cr. This month 7 funds entered and 9 funds exited. Tata India Pharma & Healthcare Fund-Direct Plan-Growth has the highest allocation at 3.26%. ↓ Scroll down for full fund list and monthly changes.
Trend

How Has Fund Coverage Changed — Last 4 Months?

Month Funds AMCs Status
May 2026 REFERENCE 110 49 / 49 ✅ Complete
Apr 2026 103 49 / 49 ✅ Complete
Mar 2026 95 48 / 49 ⏳ Partial — 48 of 49 AMCs uploaded
Feb 2026 85 46 / 49 ⏳ Partial — 46 of 49 AMCs uploaded

📌 Portfolio changes below are based on May 2026 data — the most complete month with 49 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — May 2026?

By Category

Which Fund Categories Hold This Stock?

Category Funds Avg Weight Distribution
Index/ETF 68 0.38%
Equity 19 1.17%
Mid Cap 9 0.69%
ELSS 4 0.8%
Multi Cap 2 1.03%
Multi Asset 2 0.76%
Flexi Cap 2 0.6%
Small Cap 2 0.42%
Dividend Yield 1 1.2%
Balanced Advantage 1 1%
All Holdings

Which 110 Active Funds Hold GlaxoSmithKline Pharmaceuticals Limited?

Filter:
Fund ↕ Category ↕ Weight ↕ Value ↕ Change ↕
Tata India Pharma & Healthcare Fund-Direct Plan-Growth
Tata Mutual Fund
Equity 3.26% ₹45.25 Cr +0.82%
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Equity 2.34% ₹201.84 Cr -0.21%
quant Healthcare Fund - Growth Option - Direct Plan
Quant Mutual Fund
Equity 1.93% ₹7.18 Cr -0.23%
DSP Nifty Midcap 150 Quality 50 ETF
DSP Mutual Fund
Index/ETF 1.86% ₹1.83 Cr -0.15%
DSP Nifty Midcap 150 Quality 50 Index Fund - Direct - Growth
DSP Mutual Fund
Index/ETF 1.86% ₹8.51 Cr -0.15%
UTI Nifty Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option
UTI Mutual Fund
Index/ETF 1.86% ₹4.52 Cr -0.15%
Bandhan Healthcare Fund - Direct Plan - Growth
Bandhan Mutual Fund
Equity 1.78% ₹5.53 Cr +0.01%
Kotak ESG Exclusionary Strategy Fund - Direct Plan - Growth Option
Kotak Mutual Fund
Equity 1.64% ₹12.16 Cr -0.07%
BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH
Bajaj Finserv Mutual Fund
Equity 1.58% ₹5.26 Cr -0.86%
Motilal Oswal Nifty MidSmall Healthcare Index Fund- Direct Plan-Growth
Motilal Oswal Mutual Fund
Index/ETF 1.52% ₹52.65 L -0.19%
Tata Nifty MidSmall Healthcare Index Fund - Direct Plan - Growth
Tata Mutual Fund
Index/ETF 1.52% ₹2.64 Cr -0.19%
Aditya Birla Sun Life MNC Fund - Growth - Direct Plan
Aditya Birla Sun Life Mutual Fund
Equity 1.49% ₹48.04 Cr -0.33%
BAJAJ FINSERV ELSS TAX SAVER FUND - DIRECT - GROWTH
Bajaj Finserv Mutual Fund
ELSS 1.45% ₹1.21 Cr +0.02%
Nippon India Nifty 500 Quality 50 Index Fund - Direct Plan - Growth Option
Nippon India Mutual Fund
Index/ETF 1.43% ₹63.52 L -0.1%
Axis Nifty500 Quality 50 Index Fund - Direct Plan - Growth Option
Axis Mutual Fund
Index/ETF 1.39% ₹1.11 Cr -0.11%
Explore More
← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.